261 related articles for article (PubMed ID: 19047162)
21. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
Selamnia M; Mayeur C; Robert V; Blachier F
Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
[TBL] [Abstract][Full Text] [Related]
22. Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer.
Hwang WY; Park WH; Suh DH; Kim K; Kim YB; No JH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638596
[TBL] [Abstract][Full Text] [Related]
23. Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma.
Lozier AM; Rich ME; Grawe AP; Peck AS; Zhao P; Chang AT; Bond JP; Sholler GS
Oncotarget; 2015 Jan; 6(1):196-206. PubMed ID: 25415050
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.
Geck RC; Foley JR; Murray Stewart T; Asara JM; Casero RA; Toker A
J Biol Chem; 2020 May; 295(19):6263-6277. PubMed ID: 32139506
[TBL] [Abstract][Full Text] [Related]
25. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.
Mohammed A; Janakiram NB; Madka V; Ritchie RL; Brewer M; Biddick L; Patlolla JM; Sadeghi M; Lightfoot S; Steele VE; Rao CV
Cancer Prev Res (Phila); 2014 Dec; 7(12):1198-209. PubMed ID: 25248858
[TBL] [Abstract][Full Text] [Related]
26. Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro.
Tachado SD; Li X; Swan K; Patel N; Koziel H
J Biol Chem; 2008 Nov; 283(48):33191-8. PubMed ID: 18826950
[TBL] [Abstract][Full Text] [Related]
27. Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells.
Hu X; Washington S; Verderame MF; Manni A
Cancer Res; 2005 Dec; 65(23):11026-33. PubMed ID: 16322252
[TBL] [Abstract][Full Text] [Related]
28. Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival.
Hartmann W; Küchler J; Koch A; Friedrichs N; Waha A; Endl E; Czerwitzki J; Metzger D; Steiner S; Wurst P; Leuschner I; von Schweinitz D; Buettner R; Pietsch T
Clin Cancer Res; 2009 Jul; 15(14):4538-45. PubMed ID: 19584164
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest.
Mikami I; Zhang F; Hirata T; Okamoto J; Koizumi K; Shimizu K; Jablons D; He B
Oncol Rep; 2010 Dec; 24(6):1677-81. PubMed ID: 21042767
[TBL] [Abstract][Full Text] [Related]
30. Role of tyrosine kinase, ODC, and p34cdc2 kinase and cyclin B-associated cdc2 in jejunal enterocyte proliferation, maturation, and exfoliation in diabetic and DFMO-treated rats.
Parekh VV; Hoffman JL; Younoszai MK
J Investig Med; 1999 Sep; 47(8):397-404. PubMed ID: 10510592
[TBL] [Abstract][Full Text] [Related]
31. Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of alpha-difluoromethylornithine in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Jan; 107(1):63-70. PubMed ID: 17333334
[TBL] [Abstract][Full Text] [Related]
32. Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei.
Bellofatto V; Fairlamb AH; Henderson GB; Cross GA
Mol Biochem Parasitol; 1987 Oct; 25(3):227-38. PubMed ID: 3122042
[TBL] [Abstract][Full Text] [Related]
33. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
[TBL] [Abstract][Full Text] [Related]
34. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
[TBL] [Abstract][Full Text] [Related]
35. Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO) in human breast cancer cells.
Manni A; Washington S; Mauger D; Hackett DA; Verderame MF
Clin Exp Metastasis; 2004; 21(5):461-7. PubMed ID: 15672871
[TBL] [Abstract][Full Text] [Related]
36. NMDA neuroprotection against a phosphatidylinositol-3 kinase inhibitor, LY294002 by NR2B-mediated suppression of glycogen synthase kinase-3beta-induced apoptosis.
Habas A; Kharebava G; Szatmari E; Hetman M
J Neurochem; 2006 Jan; 96(2):335-48. PubMed ID: 16300633
[TBL] [Abstract][Full Text] [Related]
37. The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.
Liu F; Gong X; Zhang G; Marquis K; Reinhart P; Andree TH
J Neurochem; 2005 Dec; 95(5):1363-72. PubMed ID: 16277616
[TBL] [Abstract][Full Text] [Related]
38. Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity.
Coons T; Hanson S; Bitonti AJ; McCann PP; Ullman B
Mol Biochem Parasitol; 1990 Feb; 39(1):77-89. PubMed ID: 2154691
[TBL] [Abstract][Full Text] [Related]
39. The effects of clozapine on the GSK-3-mediated signaling pathway.
Kang UG; Seo MS; Roh MS; Kim Y; Yoon SC; Kim YS
FEBS Lett; 2004 Feb; 560(1-3):115-9. PubMed ID: 14988008
[TBL] [Abstract][Full Text] [Related]
40. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
